United Kingdom · 
Who invested in Wild Bioscience?
Wild Bioscience's investors include Oxford Science Enterprises.
2022202320242025
$8.3MSeed$7.2MSeed$60MSeries A
United Kingdom · Series A startup
Who invested in Wild Bioscience
Funding summaryUpdated 26 Oct 2026
$76Mraised across 3 rounds since 2021, from 3 sources
$8.3MSeed$7.2MSeed$60MSeries A
- Latest round
- Series A, $60MOct 2025
- Step-upi
- 8.3×
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Seed, $8.3M Jul 2021
- Biggest round
- $60M Series A · Oct 2025
- Usual gap between rounds
- 2.8 years the median of 2
The rounds
- Oct 2025
- Dec 2022Seed$7.2M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- Jul 2021Seed$8.3M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Funding filed with regulators
Wild Bioscience filed 3 raises, $75M in all. Filings say how much was sold and to how many investors; they never name the investors.
- Nov 2025$60MUK share allotment
- Dec 2022$7.2MUK share allotment
- Jul 2021$8.3MUK share allotment
Founders and team
From Wild Bioscience's own website: 2 founders, 5 on the team.
Ross HendronCo-Founder & Chief Executive Officer
Steve KellyCo-Founder & Chief Scientific Officer
- Andrew JustoChief Finance Officer
- Sam GattisChief Technology Officer
- Stuart HarrisonChief Business Officer
- Carys JonesHead of Finance
- Rebecca KyteHead of Operations
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Wild Bioscience
How much has Wild Bioscience raised?
Wild Bioscience has raised $76M across 3 rounds since 2021.
When did Wild Bioscience last raise?
Wild Bioscience's most recent round was a Series A of $60M in Oct 2025.
What was Wild Bioscience's biggest round?
Its most recent round, $60M in Oct 2025, is also its largest on record.
Who backed Wild Bioscience first?
Wild Bioscience's first round on record, in Oct 2025, was backed by Oxford Science Enterprises.
What stage is Wild Bioscience at?
Wild Bioscience's latest named round is a Series A, in Oct 2025.
Where is Wild Bioscience based?
Wild Bioscience is based in the United Kingdom.
Companies like Wild Bioscience
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.